Abionyx Pharma
Industry
- Pharmaceuticals
- Biotechnology
Other Names/Subsidiaries
- Cerenis Therapeutics, Inc.
- Cerenis Therapeutics Holding SA
- Lypro Biosciences
- Iris Pharma Holding SAS
Latest on Abionyx Pharma
Abionyx Pharma ’s CER-001 has hit the mark in a Phase IIa sepsis-triggered acute kidney injury (AKI) trial, triggering regulatory discussions and a hunt for big pharma collaboration to support its fur
Below is Scrip’s monthly roundup, including information from Strategic Transactions , of recent technology transfer agreements between companies and academic or other research institutions. Amgen, M
The progression of investigational products through a series of increasingly more sophisticated and targeted clinical trials is a well-tried and tested route for the development of new medicines for c
The headline presentation at the American College of Cardiology annual scientific sessions, being held March 17-19 in Washington, DC, is Amgen Inc. 's FOURIER cardiovascular outcomes trial of its P